AKTS(Aktis Oncology, Inc.) · 内部人交易

AKTS(Aktis Oncology, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

AKTS 最近的内部人买卖(Form 4)
交易日姓名职务类型股数价格
2026-09-23Czibere AkosChief Medical Officer公开市场卖出7,401$21.03
2026-09-23Czibere AkosChief Medical Officer公开市场卖出5,099$20.19
2026-07-20Herrmann Ken董事公开市场卖出1,350$24.56
2026-07-20Herrmann Ken董事公开市场卖出3,506$24.56
2026-07-17Herrmann Ken董事公开市场卖出3,065$25.21
2026-07-08Ron-Bigger ShulamitChief Operating Officer公开市场卖出4,200$28.75
2026-07-08Ron-Bigger ShulamitChief Operating Officer公开市场卖出30,000$27.94
2026-07-08Ron-Bigger ShulamitChief Operating Officer公开市场卖出15,800$27.13
2026-07-08Czibere AkosChief Medical Officer公开市场卖出4,371$28.71
2026-07-08Czibere AkosChief Medical Officer公开市场卖出30,829$27.95
2026-07-08Czibere AkosChief Medical Officer公开市场卖出14,800$27.13
2026-01-12Foley Todd董事、10% 股东公开市场买入232,870$18.00
2026-01-12MPM BIOVENTURES 2018, L.P.10% 股东公开市场买入1,112,777$18.00
2026-01-12GADICKE ANSBERT10% 股东公开市场买入1,112,777$18.00
2026-01-12Vida Ventures II, LLC10% 股东公开市场买入22,545$18.00
2026-01-12Vida Ventures II, LLC10% 股东公开市场买入812,455$18.00
2026-01-12Kim Helen Susan董事、10% 股东公开市场买入22,545$18.00
2026-01-12Kim Helen Susan董事、10% 股东公开市场买入812,455$18.00
2026-01-12EcoR1 Capital, LLC董事公开市场买入144,443$18.00
2026-01-12EcoR1 Capital, LLC董事公开市场买入2,077,779$18.00

Aktis Oncology, Inc. AKTS